Leo International Precision Health AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution
Leo International Precision Health AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution
13. Oct 2026 / 08:15 CET/CEST, transmitted by GlobeNewswire.
The issuer is solely responsible for the content of this announcement.
Notification of Major Holdings
1. Details of issuer
Name | Leo International Precision Health Aktiengesellschaft |
Street address | Am Klopferspitz 19 |
Postal code | 82152 |
City | Planegg Martinsried |
LEI | 529900R5095181VD8H48 |
2. Reason for notification
Acquisition/disposal of shares with voting rights |
3. Details of person subject to the notification obligation
Natural Person
Name | Birth date |
|---|---|
Hsiao-Hsuan Wang | 03.08.1978 |
4. Name(s) of shareholder(s) holding directly 3% or more voting rights, if different from details of person subject to the notification obligation
Name |
|---|
SGCI Corporate Finance GmbH |
5. Date on which threshold was crossed or reached
02.10.2026 |
6. Total positions
% of voting rights attached to shares (total of details on total positions 7.a.) | % of voting rights through instruments (total of details on total positions 7.b.1. + 7.b.2.) | Total of both in % (details on total positions 7.a. + 7.b.) | Total number of voting rights pursuant to Sec. 41 WpHG | |
|---|---|---|---|---|
New | 69.87% | 0.00% | 69.87% | 106,560,000 |
Previous notification | 84.20% | 0% | 84.20% | – |
7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN | Absolute | In % | ||
Direct (Sec. 33 WpHG) | Indirect (Sec. 34 WpHG) | Direct (Sec. 33 WpHG) | Indirect (Sec. 34 WpHG) | |
DE0005490601 | 70,570,840 | 3,885,000 | 66.23% | 3.65% |
Total | 74,455,840 | 69.87% | ||
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument | Expiration or maturity date | Exercise or conversion period | Voting rights absolute | Voting rights in % |
|---|---|---|---|---|
0 | 0.00% | |||
Voting rights absolute | Voting rights in % | |||
Total | 0 | 0.00% | ||
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument | Expiration or maturity date | Exercise or conversion period | Cash or physical settlement | Voting rights absolute | Voting rights in % |
|---|---|---|---|---|---|
0 | 0.00% | ||||
Voting rights absolute | Voting rights in % | ||||
Total | 0 | 0.00% | |||
8. Information in relation to the person subject to the notification obligation
X | Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer |
Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity |
9. In case of proxy voting according to Sec. 34 (3) WpHG
Date of general meeting
Total positions (6.) after general meeting:
% of voting rights attached to shares | % of voting rights through instruments | Total of both |
|---|---|---|
10. Other useful information
3.885.000 Stimmrechte der SGCI Corporate Finance GmbH, Frankfurt am Main, werden dem Meldepflichtigen aufgrund einer Verhaltensabstimmung gemäß § 34 Abs. 2 WpHG wechselseitig zugerechnet. |
Date
08.10.2026 |
End of message
GlobeNewsWire Distribution Services include regulatory announcements, financial/corporate news and press releases.
Archive at www.globenewswire.com
Language | English |
Company | Leo International Precision Health AG |
Am Klopferspitz 19 | |
82152 Planegg / Martinsried | |
Germany | |
Internet | https://www.liphag.com |
